Is Metatropic Dysplasia hereditary?

Metatropic dysplasia is a genetic condition caused by mutations in the TRPV4 gene, which affects skeletal development. While it is a genetic disorder, it is most commonly the result of a de novo (spontaneous) mutation rather than being inherited from a parent.

Is metatropic dysplasia hereditary?

Metatropic dysplasia is a genetic condition, but in the vast majority of cases, it is not inherited from parents. Instead, it typically arises as a de novo mutation, meaning the genetic change occurs for the first time in the affected individual. Because the condition follows an autosomal dominant pattern of inheritance, an individual with metatropic dysplasia could theoretically pass the condition to their children, though this is rare given the clinical severity often associated with the disorder.

What is the inheritance pattern of metatropic dysplasia?

Metatropic dysplasia is characterized by an autosomal dominant inheritance pattern. This means that only one copy of the altered TRPV4 gene is required to cause the condition. When an affected individual has children, there is a 50% chance of passing the mutation to each offspring. However, because most cases of metatropic dysplasia are de novo, parents of an affected child are typically not carriers and have a very low risk of having another child with the condition.

How is metatropic dysplasia diagnosed genetically?

Genetic testing is the gold standard for confirming a diagnosis of metatropic dysplasia. Clinical confirmation involves the following steps:

• Molecular Genetic Testing: Targeted gene sequencing or multigene panels are used to identify pathogenic variants in the TRPV4 gene.


• Clinical Correlation: Geneticists compare molecular findings with specific skeletal features, such as progressive kyphoscoliosis and platyspondyly, to confirm the diagnosis.


• Genetic Counseling: Families are encouraged to meet with a counselor to discuss the implications of the TRPV4 mutation and reproductive risks.

What are the reproductive options for families?

For individuals with a confirmed TRPV4 mutation who are planning a family, genetic counseling is essential. Options may include preimplantation genetic testing (PGT) during IVF or prenatal diagnosis through amniocentesis or chorionic villus sampling (CVS). These options allow families to understand the risks and make informed reproductive decisions regarding metatropic dysplasia.

Next steps

• Consult a clinical geneticist to verify your specific TRPV4 variant.


• Connect with the 13 members of the DiseaseMaps.org community who have experience living with metatropic dysplasia.


• Request a referral to a genetic counselor to discuss family planning and recurrence risks.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Metatropic dysplasia entry.


• Orphanet: Rare disease database entry for metatropic dysplasia.


• OMIM (Online Mendelian Inheritance in Man): TRPV4 gene and associated skeletal dysplasias.


• PubMed: Clinical studies on TRPV4-related skeletal disorders.